TÜV Rheinland has participated in the EcoVadis assessment process since 2019 and has achieved at least Gold status for four consecutive years. Over this period, the company has steadily improved its ...
Sanofi has secured regulatory approval in China for two innovative medicines, Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndrome. The approvals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback